Metraipolis › archive › dc_cd33994f8bfe
Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment — Europe PMC PMID:41233583
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41233583
- DOI
- 10.1038/s43856-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T14:30:30.300Z
- SHA-256 of the archived text
e013b08d3a9cad52886413798b75cec7d439839a1c9b1554eced09d2286a9c79- Stable URL of this page
https://metraipolis.com/documento/dc_cd33994f8bfe
How to cite
Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment — Europe PMC PMID:41233583 — Europe PMC (en), https://europepmc.org/article/MED/41233583 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd33994f8bfe (Metraipolis archive dc_cd33994f8bfe, sha256 e013b08d3a9cad52886413798b75cec7d439839a1c9b1554eced09d2286a9c79)
BibTeX
@misc{dccd33994f8bfe,
title = {Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment — Europe PMC PMID:41233583},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41233583},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd33994f8bfe; sha256 e013b08d3a9cad52886413798b75cec7d439839a1c9b1554eced09d2286a9c79},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41233583. Agents can read the archived copy with the MCP tool read_document.